Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: China Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20081
20091
20114
20122
20131
20153
20161
20174
20182
20195
20204
20216
20224
20234
20248
20256
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status24
Recruiting15
Completed15
Not yet recruiting7
Active, not recruiting5
Withdrawn1
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University12
Sun Yat-sen University4
Ming-Yuan Chen3
Peking Union Medical College Hospital3
Shanghai Junshi Bioscience Co., Ltd.3
Zhejiang Cancer Hospital3
Chinese Academy of Medical Sciences2
Peking University2
Shandong Cancer Hospital and Institute2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis69
Recurrence12
Breast Neoplasms9
Stomach Neoplasms9
Nasopharyngeal Carcinoma7
Carcinoma, Non-Small-Cell Lung6
Neoplasms6
Colorectal Neoplasms5
Endometrial Neoplasms3
Lung Neoplasms3

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.